Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Teresa Rizzo

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 29, 2010
Cyclooxygenase-2 in oncogenesisMaria Teresa Rizzo
Molecular Neurobiology|April 22, 2010
Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and diseaseMaria Teresa Rizzo, H Anne Leaver
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Specificity of arachidonic acid-induced inhibition of growth and activation of c-jun kinases and p38 mitogen-activated protein kinase in hematopoietic cellsMaria Teresa Rizzo, Nancy Pudlo, Lindsey Farrell, et al.
Prostaglandins & Other Lipid Mediators|December 18, 2009
Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERKPhilip Bidwell, Kiwon Joh, H Anne Leaver, et al.
Clinical Lung Cancer|December 2, 2021
Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized StudiesEdward B Garon, Patrick Peterson, Maria Teresa Rizzo, et al.
Molecular Cancer Therapeutics|January 21, 2003
Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancerJingsong Chu, Frank L Lloyd, Ovidiu C Trifan, et al.
Experimental Cell Research|October 24, 2006
c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cellsStephen Rush, Gausal Khan, Ayoola Bamisaiye, et al.
Frontiers in Oncology|September 21, 2023
Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature reviewEdward B Garon, Carla Visseren-Grul, Maria Teresa Rizzo, et al.
JTO Clinical and Research Reports|November 21, 2022
Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189Shirish Gadgeel, Jhanelle E Gray, Maria Teresa Rizzo, et al.
Molecular Cancer Therapeutics|August 8, 2006
Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E(2)-dependent activation of type II protein kinase ATroy Payner, H Anne Leaver, Brian Knapp, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 29, 2010
Cyclooxygenase-2 in oncogenesisMaria Teresa Rizzo
Molecular Neurobiology|April 22, 2010
Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and diseaseMaria Teresa Rizzo, H Anne Leaver
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Specificity of arachidonic acid-induced inhibition of growth and activation of c-jun kinases and p38 mitogen-activated protein kinase in hematopoietic cellsMaria Teresa Rizzo, Nancy Pudlo, Lindsey Farrell, et al.
Prostaglandins & Other Lipid Mediators|December 18, 2009
Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERKPhilip Bidwell, Kiwon Joh, H Anne Leaver, et al.
Clinical Lung Cancer|December 2, 2021
Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized StudiesEdward B Garon, Patrick Peterson, Maria Teresa Rizzo, et al.
Molecular Cancer Therapeutics|January 21, 2003
Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancerJingsong Chu, Frank L Lloyd, Ovidiu C Trifan, et al.
Experimental Cell Research|October 24, 2006
c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cellsStephen Rush, Gausal Khan, Ayoola Bamisaiye, et al.
Frontiers in Oncology|September 21, 2023
Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature reviewEdward B Garon, Carla Visseren-Grul, Maria Teresa Rizzo, et al.
JTO Clinical and Research Reports|November 21, 2022
Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189Shirish Gadgeel, Jhanelle E Gray, Maria Teresa Rizzo, et al.
Molecular Cancer Therapeutics|August 8, 2006
Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E(2)-dependent activation of type II protein kinase ATroy Payner, H Anne Leaver, Brian Knapp, et al.
Pageof 2